State of Wisconsin Investment Board’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,270
| Closed | -$632K | – | 2479 |
|
|
2023
Q3 | $632K | Buy |
13,270
+8,903
| +204% | +$424K | ﹤0.01% | 1602 |
|
|
2023
Q2 | $418K | Sell |
4,367
-230
| -5% | -$22K | ﹤0.01% | 1877 |
|
|
2023
Q1 | $521K | Sell |
4,597
-1,012
| -18% | -$115K | ﹤0.01% | 1852 |
|
|
2022
Q4 | $628K | Sell |
5,609
-4,185
| -43% | -$469K | ﹤0.01% | 1794 |
|
|
2022
Q3 | $1.26M | Buy |
9,794
+1,494
| +18% | +$192K | ﹤0.01% | 1462 |
|
|
2022
Q2 | $569K | Buy |
8,300
+3,795
| +84% | +$260K | ﹤0.01% | 2013 |
|
|
2022
Q1 | $642K | Hold |
4,505
| – | – | ﹤0.01% | 1734 |
|
|
2021
Q4 | $751K | Hold |
4,505
| – | – | ﹤0.01% | 1536 |
|
|
2021
Q3 | $627K | Sell |
4,505
-793
| -15% | -$110K | ﹤0.01% | 1614 |
|
|
2021
Q2 | $2.53M | Buy |
5,298
+768
| +17% | +$366K | 0.01% | 1231 |
|
|
2021
Q1 | $1.87M | Buy |
4,530
+170
| +4% | +$70K | ﹤0.01% | 1247 |
|
|
2020
Q4 | $2.14M | Buy |
4,360
+925
| +27% | +$453K | ﹤0.01% | 1178 |
|
|
2020
Q3 | $1.95M | Buy |
3,435
+480
| +16% | +$272K | ﹤0.01% | 1155 |
|
|
2020
Q2 | $281K | Buy |
2,955
+135
| +5% | +$12.8K | ﹤0.01% | 1564 |
|
|
2020
Q1 | $201K | Buy |
2,820
+1,405
| +99% | +$100K | ﹤0.01% | 1563 |
|
|
2019
Q4 | $98K | Hold |
1,415
| – | – | ﹤0.01% | 1599 |
|
|
2019
Q3 | $113K | Hold |
1,415
| – | – | ﹤0.01% | 1529 |
|
|
2019
Q2 | $91K | Buy |
1,415
+30
| +2% | +$1.93K | ﹤0.01% | 1525 |
|
|
2019
Q1 | $190K | Buy |
1,385
+320
| +30% | +$43.9K | ﹤0.01% | 1465 |
|
|
2018
Q4 | $96K | Buy |
1,065
+315
| +42% | +$28.4K | ﹤0.01% | 1499 |
|
|
2018
Q3 | $114K | Hold |
750
| – | – | ﹤0.01% | 1521 |
|
|
2018
Q2 | $129K | Hold |
750
| – | – | ﹤0.01% | 1448 |
|
|
2018
Q1 | $110K | Hold |
750
| – | – | ﹤0.01% | 1431 |
|
|
2017
Q4 | $152K | Hold |
750
| – | – | ﹤0.01% | 1406 |
|
|
2017
Q3 | $241K | Hold |
750
| – | – | ﹤0.01% | 1384 |
|
|
2017
Q2 | $169K | Buy |
+750
| New | +$169K | ﹤0.01% | 1410 |
|